US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 4.670
  • 0.0000.00%
Close Jul 26 16:00 ET
  • 4.670
  • 0.0000.00%
Post 20:01 ET
284.12MMarket Cap-1860P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
1.06M
0
0
0
0
0
0
0
0
0
Operating revenue
--1.06M
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
5.11%36.01M
27.52%143.31M
7.31%34.86M
30.34%36.97M
36.69%37.22M
40.97%34.26M
54.20%112.38M
38.92%32.49M
42.75%28.36M
50.26%27.23M
Selling and administrative expenses
19.74%8.99M
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
47.70%7.02M
80.58%6.3M
-General and administrative expense
19.74%8.99M
17.26%32.04M
1.40%7.73M
23.38%8.66M
29.39%8.15M
17.49%7.5M
73.73%27.32M
44.97%7.62M
47.70%7.02M
80.58%6.3M
Research and development costs
1.01%27.03M
30.81%111.27M
9.12%27.14M
32.63%28.31M
38.88%29.08M
49.34%26.76M
48.83%85.06M
37.16%24.87M
41.20%21.34M
43.03%20.94M
Operating profit
-2.01%-34.95M
-27.52%-143.31M
-7.31%-34.86M
-30.34%-36.97M
-36.69%-37.22M
-40.97%-34.26M
-54.20%-112.38M
-38.92%-32.49M
-42.75%-28.36M
-50.26%-27.23M
Net non-operating interest income expense
0.21%2.44M
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
7,569.23%997K
4,385.71%628K
Non-operating interest income
0.21%2.44M
147.98%9.33M
18.99%2.37M
123.37%2.23M
266.56%2.3M
1,535.57%2.44M
8,082.61%3.76M
15,207.69%1.99M
7,569.23%997K
4,385.71%628K
Other net income (expense)
387.04%620K
-971.43%-1.04M
-175.27%-779K
-42.55%27K
-151.49%-69K
-197.74%-216K
110.61%119K
-328.79%-283K
161.11%47K
145.27%134K
Gain on sale of security
387.04%620K
-10,710.00%-1.06M
-175.27%-779K
-57.14%27K
-169.40%-93K
-325.00%-216K
106.17%10K
-328.79%-283K
250.00%63K
145.27%134K
Special income (charges)
----
-77.98%24K
--0
--0
--24K
----
--109K
--0
---16K
--0
-Gain on sale of property,plant,equipment
----
-77.98%24K
--0
--0
--24K
----
--109K
--0
---16K
--0
Income before tax
0.48%-31.89M
-24.44%-135.01M
-8.10%-33.27M
-27.07%-34.71M
-32.18%-34.99M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
Income tax
83K
338K
-22K
170K
190K
0
0
0
0
0
Net income
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
Net income continuous Operations
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.69%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
Minority interest income
Net income attributable to the parent company
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
0.22%-31.97M
-24.75%-135.35M
-8.02%-33.25M
-27.70%-34.88M
-32.90%-35.18M
-33.87%-32.04M
-46.71%-108.5M
-31.32%-30.78M
-37.71%-27.32M
-43.81%-26.47M
Basic earnings per share
18.46%-0.53
-14.35%-2.63
7.94%-0.58
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
-34.88%-0.58
84.30%-0.57
Diluted earnings per share
18.46%-0.53
-14.35%-2.63
7.94%-0.58
-20.69%-0.7
-24.56%-0.71
-27.45%-0.65
22.30%-2.3
-25.08%-0.63
-34.88%-0.58
84.30%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 1.06M000000000
Operating revenue --1.06M--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 5.11%36.01M27.52%143.31M7.31%34.86M30.34%36.97M36.69%37.22M40.97%34.26M54.20%112.38M38.92%32.49M42.75%28.36M50.26%27.23M
Selling and administrative expenses 19.74%8.99M17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M47.70%7.02M80.58%6.3M
-General and administrative expense 19.74%8.99M17.26%32.04M1.40%7.73M23.38%8.66M29.39%8.15M17.49%7.5M73.73%27.32M44.97%7.62M47.70%7.02M80.58%6.3M
Research and development costs 1.01%27.03M30.81%111.27M9.12%27.14M32.63%28.31M38.88%29.08M49.34%26.76M48.83%85.06M37.16%24.87M41.20%21.34M43.03%20.94M
Operating profit -2.01%-34.95M-27.52%-143.31M-7.31%-34.86M-30.34%-36.97M-36.69%-37.22M-40.97%-34.26M-54.20%-112.38M-38.92%-32.49M-42.75%-28.36M-50.26%-27.23M
Net non-operating interest income expense 0.21%2.44M147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M7,569.23%997K4,385.71%628K
Non-operating interest income 0.21%2.44M147.98%9.33M18.99%2.37M123.37%2.23M266.56%2.3M1,535.57%2.44M8,082.61%3.76M15,207.69%1.99M7,569.23%997K4,385.71%628K
Other net income (expense) 387.04%620K-971.43%-1.04M-175.27%-779K-42.55%27K-151.49%-69K-197.74%-216K110.61%119K-328.79%-283K161.11%47K145.27%134K
Gain on sale of security 387.04%620K-10,710.00%-1.06M-175.27%-779K-57.14%27K-169.40%-93K-325.00%-216K106.17%10K-328.79%-283K250.00%63K145.27%134K
Special income (charges) -----77.98%24K--0--0--24K------109K--0---16K--0
-Gain on sale of property,plant,equipment -----77.98%24K--0--0--24K------109K--0---16K--0
Income before tax 0.48%-31.89M-24.44%-135.01M-8.10%-33.27M-27.07%-34.71M-32.18%-34.99M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M
Income tax 83K338K-22K170K190K00000
Net income 0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M
Net income continuous Operations 0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.69%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M
Minority interest income
Net income attributable to the parent company 0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 0.22%-31.97M-24.75%-135.35M-8.02%-33.25M-27.70%-34.88M-32.90%-35.18M-33.87%-32.04M-46.71%-108.5M-31.32%-30.78M-37.71%-27.32M-43.81%-26.47M
Basic earnings per share 18.46%-0.53-14.35%-2.637.94%-0.58-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63-34.88%-0.5884.30%-0.57
Diluted earnings per share 18.46%-0.53-14.35%-2.637.94%-0.58-20.69%-0.7-24.56%-0.71-27.45%-0.6522.30%-2.3-25.08%-0.63-34.88%-0.5884.30%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg